# FDA EIR - Nexgen Pharma Inc - January 31, 2020

Source: https://www.globalkeysolutions.net/records/eir/nexgen-pharma-inc/13492247-17d9-44c5-9cf1-1719037c1c55

> FDA EIR for Nexgen Pharma Inc on January 31, 2020. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: EIR
- Company Name: Nexgen Pharma Inc
- Inspection Date: 2020-01-31
- Product Type: drugs
- Office Name: Denver District Office

## Related Documents

- [WARNING_LETTER - 2010-05-25](https://www.globalkeysolutions.net/records/warning_letter/nexgen-pharma-inc/646a7714-6654-4344-8f01-8488256c3ad4)
- [EIR - 2018-08-17](https://www.globalkeysolutions.net/records/eir/nexgen-pharma-inc/39da8d78-2815-4093-9b1a-605f23f4fb8f)
- [EIR - 2020-01-31](https://www.globalkeysolutions.net/records/eir/nexgen-pharma-inc/b7c8aabb-29fa-44e7-9e96-6b9679647d31)
- [483 - Unknown Date](https://www.globalkeysolutions.net/records/483/nexgen-pharma-inc/29c0dd9d-5c64-4e84-b745-f9f34d6be502)

## Related Officers

- [company_representative](https://www.globalkeysolutions.net/people/gary-p-korngold/08be5ad1-0c3c-4719-98cb-febdeeb443df)
- [company_representative](https://www.globalkeysolutions.net/people/marcos-arellano/10574cf2-a89d-4f03-9ae3-45e6aab7f433)
- [company_representative](https://www.globalkeysolutions.net/people/ana-e-bohorquez/4f70f2c3-bd8d-449f-81d2-ce4cef3e82fc)
- [recipient](https://www.globalkeysolutions.net/people/deepak-thassu/58ff0e47-71e1-4614-9671-ef898de8c2d8)
- [company_representative](https://www.globalkeysolutions.net/people/kerry-elder/64b0cc9d-9a82-459c-8e3e-4937682746f8)

Company: https://www.globalkeysolutions.net/companies/nexgen-pharma-inc/0037b90e-6e17-411b-b1e8-60f4e8943669

Office: https://www.globalkeysolutions.net/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face